Shareholders who have suffered losses can register their claims on the relevant platform. The company remains under formal investigation by the China Securities Regulatory Commission (CSRC), a status that has persisted into early 2026. For affected investors, the claim process against OURGAME is still ongoing.

1. Ongoing Regulatory Investigation Since late 2023, when it self-reported issues including improper guarantees and unauthorized loans—major internal control failures—OURGAME has been under intense scrutiny. Although the company has attempted over the past year to legally distance itself from joint liabilities with its former actual controller, Zhang Xi, and has worked to rectify its internal control systems, regulatory accountability efforts have not ceased.

OURGAME is currently subject to a CSRC investigation, which remained active as of early 2026. Investors who incurred losses are still being sought for the collective claim action. According to lawyer Liu Peng from Shanghai Huzi Law Firm, investors who purchased shares between June 12, 2018, and November 28, 2023, and sold them after November 29, 2023, or continue to hold them at a loss, may be eligible to participate in the claim to recover losses. Eligible investors are advised not to forgo the opportunity to seek legal recourse, closely monitor subsequent CSRC investigation announcements, and promptly consult with professional legal counsel to protect their rights.

2. History of Multiple Violations OURGAME's crisis emerged in November 2023. At that time, the company announced that through self-inspection, it had discovered a series of improper guarantees provided for its former actual controller and then-chairman, Zhang Xi, and his affiliates, as well as unauthorized loans signed in the company's name by Zhang Xi. These activities were conducted without undergoing the company's requisite internal approval and decision-making processes, representing a classic case of internal control failure.

This series of violations directly breached regulatory red lines. By the end of November 2023, the CSRC decided to investigate OURGAME for suspected violations of information disclosure rules. Subsequently, in 2024, the company received another formal investigation notice from the CSRC. More severely, due to significant internal control deficiencies, the auditing firm issued qualified audit opinions on OURGAME's financial statements for both 2023 and 2024, leading to the company's stock being placed under Special Treatment (ST), a status it has not yet exited.

While a formal penalty decision has not been issued, the claim process continues to advance.